Market noise is relentless. Financial headlines scream about the same handful of stocks while important opportunities—the kind that can meaningfully impact your portfolio—often fly completely under the radar.
That’s exactly why we publish this watchlist each week.
While most investors are distracted by mainstream narratives, we’re digging through earnings transcripts, analyzing technical setups, and monitoring institutional money flows to identify companies at potential inflection points. Our focus isn’t on what’s already priced in, but rather on what the market hasn’t fully appreciated yet.
Each week, we spotlight three stocks that merit your attention. We focus on opportunities where timing, valuation, and catalysts align to create potentially favorable entry points.
Our rigorous analysis goes beyond surface-level metrics to identify opportunities that most retail investors don’t have time to uncover. Each pick comes with clear reasoning, specific triggers to watch for, and a compelling risk-reward profile designed to help you make more informed investment decisions.
Here’s what we’re watching this week:
Brookfield Asset Management (BAM) — Canadian Giant Targeting 15% Annual Dividend Growth
Brookfield Asset Management represents an exceptional growth and income opportunity as the Canadian financial giant recently increased its dividend 15% while targeting continued double-digit annual raises through at least 2030. Trading around $53 per share with an $85 billion market capitalization and offering a 3.4% dividend yield—nearly triple the S&P 500’s 1.2%—the company has successfully executed an ambitious growth strategy by doubling fee-bearing capital from $277 billion in 2020 to $563 billion in 2025, achieving roughly 15% annualized growth that supported a matching 15% annualized increase in fee-related earnings.
The investment thesis centers on management’s proven execution capabilities and ambitious yet achievable plan to double fee-bearing capital again by 2030, reaching approximately $1.2 trillion. Having successfully accomplished this exact goal once already demonstrates management credibility and operational excellence. The company operates across five major investment platforms including infrastructure, renewable power, private equity, real estate, and credit, positioning itself as a major player in each competitive area while focusing on three transformative themes: digitization, deglobalization, and decarbonization that management views as a collective $100 trillion opportunity.
The financial outlook supports exceptional dividend growth with management expecting fee-bearing capital expansion to drive approximately 17% annualized growth in fee-related earnings. This earnings trajectory should comfortably support the projected double-digit dividend increases, with 15% annual growth potentially doubling the dividend within five years. The combination of current 3.4% yield with projected 15% annual dividend growth creates a rare growth-and-income profile appealing to both dividend investors seeking reliable income and total return investors targeting capital appreciation.
The key risk involves inherent reliance on capital markets conditions, as bear markets would make the fee-bearing capital doubling goal more challenging while bull markets would ease achievement. Like most asset managers, Brookfield’s stock price and business performance fluctuate with broader markets. However, the company’s diversification across five investment platforms and focus on secular megatrends provides some insulation from single-market exposures. For investors seeking combination of attractive current yield and robust growth prospects backed by proven management execution, Brookfield Asset Management’s 3.4% yield with 15% projected annual dividend increases creates compelling risk-adjusted total return potential.
MP Materials (MP) — Rare Earth Mining Leader With Government Backing
MP Materials presents a compelling strategic opportunity as the only active rare earth mine operator in the United States positions itself to benefit from massive government support securing domestic supply chains. Trading around $62 per share with an $11 billion market capitalization after surging 254% year-to-date, the company operates the Mountain Pass mine in California while developing rare earth magnet manufacturing capabilities essential for electronics, semiconductors, robotics, defense technologies, wind turbines, and electric vehicles. BMO Capital Markets upgraded MP Materials to outperform with a $75 price target implying 36% additional upside despite the massive year-to-date rally.
The fundamental thesis centers on MP Materials’ unique positioning as China controls nearly 70% of global rare earth extraction with 80% of U.S.-consumed rare earth elements imported primarily from China. This concentration creates significant supply risks for critical technologies, prompting President Trump to allocate billions toward critical mineral projects and take equity stakes in domestic producers. In July 2025, the Department of Defense acquired a 15% stake in MP Materials becoming its largest shareholder, while committing to purchase 100% of rare earth magnets produced at MP Materials’ 10X facility for 10 years.
Major commercial partnerships validate MP Materials’ strategic positioning and provide substantial revenue visibility. The $500 million multiyear agreement with Apple supplies magnets for consumer electronics, while the joint venture partnership with the Department of Defense and Saudi Arabian Mining Company Maaden develops a rare earth refinery in Saudi Arabia with MP Materials and the Pentagon holding a combined 49% stake. The DoD will finance the U.S. share of development capital expenditures, significantly reducing MP Materials’ funding requirements while cementing government support.
BMO analyst Raj Ray emphasized that recent U.S.-China tensions “have highlighted the vulnerability of the U.S. supply chain” and believes temporary export ban halts “will not deter the U.S. from pursuing its policy goals of on shoring rare earth supply.” The analyst sees multiple growth catalysts including additional production from the Apple recycling partnership and new 10X offtake contracts with more lucrative pricing compared to existing agreements. MP Materials currently produces rare earth oxides and metals with magnet production beginning by year-end 2025, creating a vertically integrated supply chain from mining through finished magnets. For investors seeking exposure to critical minerals reshoring through the only domestic rare earth miner with government backing and major commercial partnerships, MP Materials’ combination of strategic necessity and operational execution creates substantial long-term upside despite the strong year-to-date performance.
Medtronic (MDT) — Medical Device Leader With Surgical Robotics Upside
Medtronic represents an attractive value alternative in surgical robotics as the diversified medical device giant pursues the high-growth robotic surgery market at a fraction of pure-play competitor valuations. Trading around $105 per share with a $135 billion market capitalization and offering a 2.7% dividend yield backed by 48 consecutive years of annual increases, Medtronic trades at a 28 price-to-earnings ratio—less than half the 74 P/E commanded by surgical robotics leader Intuitive Surgical despite pursuing the same opportunity.
The investment thesis centers on replicating Intuitive Surgical’s successful flywheel business model where surgical robots drive recurring revenue from parts, services, and instruments. Intuitive expanded its installed robot base 13% in Q3 2025 while surgeries performed increased 20%, with approximately 75% of revenue coming from high-margin recurring streams creating an annuity-like business. While surgical robots remain fairly new for Medtronic requiring catch-up versus the established leader, the company’s diversified medical device portfolio provides financial stability to fund robotic surgery investments while maintaining attractive dividend payments.
Medtronic’s competitive advantages extend beyond robotics through its comprehensive medical device portfolio spanning cardiovascular, diabetes, neuroscience, and surgical solutions. Management is strategically streamlining operations by focusing on the most profitable products while investing in high-growth areas like surgical robotics. This balanced approach allows Medtronic to participate in transformative surgical technology trends while maintaining the diversification and cash flow characteristics that have supported 48 consecutive annual dividend increases.
The valuation discount versus Intuitive Surgical appears excessive given Medtronic’s execution capabilities, financial resources, and proven track record of success across multiple medical device categories. While Intuitive commands premium multiples reflecting its market leadership and pure-play exposure, investors receive no dividend for accepting single-product concentration risk. Medtronic offers 2.7% current yield with projected dividend growth, diversification benefits reducing execution risk, and meaningful upside optionality if surgical robotics gains traction. For conservative healthcare investors seeking combination of dividend income, diversification, and growth exposure through surgical robotics, Medtronic’s 28 P/E with 2.7% yield and proven management creates superior risk-adjusted returns versus paying 74 times earnings for undiversified surgical robotics exposure.
